5 Most Oversold Healthcare Stocks to Invest In

3. Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the most oversold healthcare stocks to invest in. Truist cut the price target on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) to $505 from $515 on April 13, reiterating a Buy rating on the shares. The rating update came as part of a broader research note previewing Q1 results among Biotech names. The firm told investors in a research note that although management was confident in robust year-over-year growth, it cautioned for fiscal Q1 seasonal weakness in the United States from typical payer dynamics and 2 fewer shipping weeks.

In a separate development, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced on March 24 a set of strategic efforts aimed at accelerating earlier recognition and improving care coordination for patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM). The company is advancing, through complementary initiatives with Viz.ai and the American Heart Association, a comprehensive, system‑level approach addressing the continuous challenges of underdiagnosis and fragmented care in ATTR‑CM.

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is a biopharmaceutical company that develops and commercializes novel therapeutics based on ribonucleic acid interference.